Exact Mass: 436.26721900000007

Exact Mass Matches: 436.26721900000007

Found 500 metabolites which its exact mass value is equals to given mass value 436.26721900000007, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

DHAP(18:0)

1-Octadecanoyl Dihydroxyacetone phosphate;1-stearoylglycerone 3-phosphate

C21H41O7P (436.25897660000004)


DHAP(18:0) is the octadecanoyl derivative of Dihydroxyacetone phosphate. It is also known as an alkyl-DHAP. This compound is formed by octadecanoic acid reacting with DHAP. Alkyl-DHAPs are intermediates in the synthesis of ether phospholipids. The initial steps of ether phospholipid biosynthesis take place in peroxisomes. Alkyl-dihydroxyacetonephosphate synthase is the peroxisomal enzyme that actually introduces the ether linkage. Levels of Alkyl-DHAP have been found to be strongly reduced in human fibroblasts derived from Zellweger syndrome and rhizomelic chondrodysplasia punctata patients. Four other enzymes are known to be involved in the metabolism of acyl-DHAP and alkyl-DHAP. These include: acyl-DHAP/alkyl-DHAP oxidoreductase, DHAP acyltransferase, alkyl-DHAP phosphohydrolase, and a dinitrofluorobenzene-insensitive acyl-DHAP acylhydrolase. Dihydroxyacetone phosphate (DHAP) is a biochemical compound primarily involved in the glycolysis metabolic pathway. DHAP is also the product of the dehydrogenation of L-glycerol-3-phosphate which is part of the entry of glycerol (sourced from triglycerides) into the glycolytic pathway. Conversely, reduction of glycolysis-derived DHAP to L-glycerol-3-phosphate provides adipose cells with the activated glycerol backbone they require to synthesize new triglycerides. Both reactions are catalyzed by the enzyme glycerol 3-phosphate dehydrogenase with NAD+/NADH as cofactor. DHAP may be referred to as glycerone phosphate in older texts. 1-Octadecyl-glycerone-3-phosphate is an intermediate in Ether lipid metabolism. DHAP(18:0) or 1-Octadecanoyl-glycerone-3-phosphate is the precursor to 1-Octadecyl-glycerone-3-phosphate DHAP(18:0e) which is generated via alkylglycerone phosphate synthase (EC: 2.5.1.26). Ether lipids are lipids in which one or more of the carbon atoms on glycerol is bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage. Ether lipids are called plasmalogens (1-O-1-alkenyl-2-acylglycerophospholipids) if these are glycerol-containing phospholipids with an unsaturated O-(1-alkenyl) (vinyl ether) group at the first position on the glycerol chain. Plasmalogens as well as some 1-O-alkyl lipids are ubiquitous and sometimes major parts of the cell membranes in mammals and anaerobic bacteria. In archaea, ether lipids are the major polar lipids in the cell envelope and their abundance is one of the major characteristics that separate this group of prokaryotes from the bacteria. In these cells, diphytanylglycerolipids or bipolar macrocyclic tetraethers can form covalently linked bilayers. [HMDB] DHAP(18:0) is the octadecanoyl derivative of dihydroxyacetone phosphate. It is also known as an alkyl-DHAP. This compound is formed by octadecanoic acid reacting with DHAP. Alkyl-DHAPs are intermediates in the synthesis of ether phospholipids. The initial steps of ether phospholipid biosynthesis take place in peroxisomes. Alkyl-dihydroxyacetonephosphate synthase is the peroxisomal enzyme that actually introduces the ether linkage. Levels of Alkyl-DHAP have been found to be strongly reduced in human fibroblasts derived from Zellweger syndrome and rhizomelic chondrodysplasia punctata patients. Four other enzymes are known to be involved in the metabolism of acyl-DHAP and alkyl-DHAP. These include: acyl-DHAP/alkyl-DHAP oxidoreductase, DHAP acyltransferase, alkyl-DHAP phosphohydrolase, and a dinitrofluorobenzene-insensitive acyl-DHAP acylhydrolase. Dihydroxyacetone phosphate (DHAP) is a biochemical compound primarily involved in the glycolysis metabolic pathway. DHAP is also the product of the dehydrogenation of L-glycerol-3-phosphate which is part of the entry of glycerol (sourced from triglycerides) into the glycolytic pathway. Conversely, reduction of glycolysis-derived DHAP to L-glycerol-3-phosphate provides adipose cells with the activated glycerol backbone they require to synthesize new triglycerides. Both reactions are catalyzed by the enzyme glycerol 3-phosphate dehydrogenase with NAD+/NADH as cofactor. DHAP may be referred to as glycerone phosphate in older texts. 1-Octadecyl-glycerone-3-phosphate is an intermediate in Ether lipid metabolism. DHAP(18:0) or 1-Octadecanoyl-glycerone-3-phosphate is the precursor to 1-Octadecyl-glycerone-3-phosphate DHAP(18:0e) which is generated via alkylglycerone phosphate synthase (EC: 2.5.1.26). Ether lipids are lipids in which one or more of the carbon atoms on glycerol is bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage. Ether lipids are called plasmalogens (1-O-1-alkenyl-2-acylglycerophospholipids) if these are glycerol-containing phospholipids with an unsaturated O-(1-alkenyl) (vinyl ether) group at the first position on the glycerol chain. Plasmalogens as well as some 1-O-alkyl lipids are ubiquitous and sometimes major parts of the cell membranes in mammals and anaerobic bacteria. In archaea, ether lipids are the major polar lipids in the cell envelope and their abundance is one of the major characteristics that separate this group of prokaryotes from the bacteria. In these cells, diphytanylglycerolipids or bipolar macrocyclic tetraethers can form covalently linked bilayers. (Wikipedia)

   

HC Toxin

(6R,9S,14aR)-3,6R-dimethyl-9S-(7-((S)-oxiran-2-yl)-7-oxoheptyl)decahydropyrrolo[1,2-a][1,4,7,10]tetraazacyclododecine-1,4,7,10-tetranone

C21H32N4O6 (436.2321732)


A homodetic cyclic tetrapeptide made up from L-alanyl, D-alanyl, L-prolyl and 2-amino-8-oxo-9,10-epoxydecanoyl residues.

   

simvastatin hydroxy acid

(3R,5R)-7-[(1S,2S,6R,8S,8aR)-8-[(2,2-dimethylbutanoyl)oxy]-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid

C25H40O6 (436.28247400000004)


simvastatin hydroxy acid is a metabolite of simvastatin. Simvastatin is a hypolipidemic drug used to control elevated cholesterol, or hypercholesterolemia. It is a member of the statin class of pharmaceuticals. Simvastatin is a synthetic derivate of a fermentation product of Aspergillus terreus. The drug is marketed generically and under the trade name Zocor. (Wikipedia) C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent C471 - Enzyme Inhibitor > C1655 - HMG-CoA Reductase Inhibitor

   

LysoPA(18:1(9Z)/0:0)

9-Octadecenoic acid (9Z)-, 2-hydroxy-3-(phosphonooxy)propyl ester

C21H41O7P (436.25897660000004)


LysoPA(18:1(9Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes. In particular, lysophosphatidic acid is an intercellular lipid mediator with growth factor-like activities, and is rapidly produced and released from activated platelets to influence target cells. 1-Palmitoyl lysophosphatidic acid is the major component of lysophosphatidic acid (LPA) in plasma, and is in a reduced ratio in individuals with gynecological cancers (PMID 11585410). LPA is a pluripotent lipid mediator controlling growth, motility, and differentiation, that has a strong influence on the chemotaxis and ultrastructure of human neutrophils (PMID 7416233). In serum and plasma, LPA is mainly converted from lysophospholipids, whereas in platelets and some cancer cells it is converted from phosphatidic acid. In each pathway, at least two phospholipase activities are required: phospholipase A1 (PLA1)/PLA2 plus lysophospholipase D (lysoPLD) activities are involved in the first pathway and phospholipase D (PLD) plus PLA1/PLA2 activities are involved in the second pathway. (PMID 15271293).

   

Pangamic acid

6-({2,2-bis[bis(propan-2-yl)amino]acetyl}oxy)-2,3,4,5-tetrahydroxyhexanoic acid

C20H40N2O8 (436.278452)


Pangamic acid is found in apricot. Pangamic acid is isolated from apricot kernel, also said to be present in cereals etc. Said to be a vitamin of significance in, inter alia, hypertension control Pangamic acid is also known as vitamin B15, but it is not widely accepted as a vitamin for it has not been shown to be essential in the human diet, and a deficiency in consumption of pangamic acid is not known to be associated with any disease. Pangamic acid is an ester derived from gluconic acid and dimethylglycine. It was first isolated by Ernst T. Krebs from apricot kernels, and has since been identified in some foods such as pulses. Also found in rice bran & apricot kernels Isolated from apricot kernel, also said to be present in cereals etc. Said to be a vitamin of significance in, inter alia, hypertension control

   

LysoPA(0:0/18:1(9Z))

{3-hydroxy-2-[(9Z)-octadec-9-enoyloxy]propoxy}phosphonic acid

C21H41O7P (436.25897660000004)


LysoPA(0:0/18:1(9Z)) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes. In particular, lysophosphatidic acid is an intercellular lipid mediator with growth factor-like activities, and is rapidly produced and released from activated platelets to influence target cells. 1-Palmitoyl lysophosphatidic acid is the major component of lysophosphatidic acid (LPA) in plasma, and is in a reduced ratio in individuals with gynecological cancers (PMID 11585410). LPA is a pluripotent lipid mediator controlling growth, motility, and differentiation, that has a strong influence on the chemotaxis and ultrastructure of human neutrophils (PMID 7416233). In serum and plasma, LPA is mainly converted from lysophospholipids, whereas in platelets and some cancer cells it is converted from phosphatidic acid. In each pathway, at least two phospholipase activities are required: phospholipase A1 (PLA1)/PLA2 plus lysophospholipase D (lysoPLD) activities are involved in the first pathway and phospholipase D (PLD) plus PLA1/PLA2 activities are involved in the second pathway. (PMID 15271293).

   

(R)-1-O-[b-D-Apiofuranosyl-(1->2)-b-D-glucopyranoside]-1,3-octanediol

3-{[3-hydroxy-4-(hydroxymethyl)-4-methyloxolan-2-yl]oxy}-6-(hydroxymethyl)-2-[(3-hydroxyoctyl)oxy]-5-methyloxan-4-ol

C21H40O9 (436.26721900000007)


(R)-1-O-[b-D-Apiofuranosyl-(1->2)-b-D-glucopyranoside]-1,3-octanediol is found in fruits. (R)-1-O-[b-D-Apiofuranosyl-(1->2)-b-D-glucopyranoside]-1,3-octanediol is a constituent of calabash tree (Crescentia cujete) fruits. Constituent of calabash tree (Crescentia cujete) fruits. (R)-1-O-[b-D-Apiofuranosyl-(1->2)-b-D-glucopyranoside]-1,3-octanediol is found in fruits.

   

(2-Hydroxy-3-phosphonooxypropyl) octadec-9-enoate

9-Octadecenoic acid (9Z)-, 2-hydroxy-3-(phosphonooxy)propyl ester

C21H41O7P (436.25897660000004)


   

DN-isobutylamide

N-[1-(2-carbamoylpyrrolidin-1-yl)-3-(3H-imidazol-4-yl)-1-oxopropan-2-yl]-2-hydroxy-N-(2-methylpropyl)pentanediamide

C20H32N6O5 (436.2434062)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

N,N-Dihexyl-2-(4-fluorophenyl)indole-3-acetamide

2-[2-(4-fluorophenyl)-1H-indol-3-yl]-N,N-dihexylacetamide

C28H37FN2O (436.28897639999997)


   

DG(2:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C25H40O6 (436.28247400000004)


DG(2:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C25H40O6 (436.28247400000004)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C25H40O6 (436.28247400000004)


DG(2:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C25H40O6 (436.28247400000004)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoic acid

C25H40O6 (436.28247400000004)


DG(2:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoic acid

C25H40O6 (436.28247400000004)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoic acid

C25H40O6 (436.28247400000004)


DG(2:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoic acid

C25H40O6 (436.28247400000004)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoic acid

C25H40O6 (436.28247400000004)


DG(2:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoic acid

C25H40O6 (436.28247400000004)


DG(20:3(5Z,11Z,14Z)-O(8,9)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoic acid

C25H40O6 (436.28247400000004)


DG(2:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoic acid

C25H40O6 (436.28247400000004)


DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl 4-{3-[(2Z,5Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoic acid

C25H40O6 (436.28247400000004)


DG(2:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl 4-{3-[(2Z,5Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoic acid

C25H40O6 (436.28247400000004)


DG(20:3(8Z,11Z,14Z)-O(5,6)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

(2R)-3-(Acetyloxy)-2-hydroxypropyl 4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoic acid

C25H40O6 (436.28247400000004)


DG(2:0/0:0/20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl 4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoic acid

C25H40O6 (436.28247400000004)


DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5R,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(2:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5S,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(2:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5Z,8Z,11Z,14Z,19S)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5Z,8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

(2R)-3-(acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoate

C25H40O6 (436.28247400000004)


DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/2:0)

(2S)-3-(acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoate

C25H40O6 (436.28247400000004)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5Z,8Z,11Z,14Z,18R)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5Z,8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5Z,8Z,11Z,14Z,16R)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (8Z,11Z,13E,15S)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(2:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(2:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

(2S)-1-(acetyloxy)-3-hydroxypropan-2-yl (5Z,8Z,10E,12S,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoate

C25H40O6 (436.28247400000004)


DG(2:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/2:0/0:0)

(2S)-2-(acetyloxy)-3-hydroxypropyl (5Z,8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoate

C25H40O6 (436.28247400000004)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(2:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/2:0)

(2S)-3-(acetyloxy)-2-hydroxypropyl (5Z,8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoate

C25H40O6 (436.28247400000004)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5E,8Z,11R,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(2:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(2:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(2:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,7E,11Z,14Z)-OH(9)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(2:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C25H40O6 (436.28247400000004)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

Lancifodilactone F

(2S)-2-{(3R,3aR,5aR,7R,8S,10aS,10bS)-8-[(2S)-1,2-dihydroxypropan-2-yl]-3a,10b-dimethyl-5-oxotetradecahydro-1H,3H-spiro[cyclohepta[e]indene-7,2-furan]-3-yl}propanoic acid

C25H40O6 (436.28247400000004)


Lancifodilactone F is a tetracyclic triterpenoid that is a rearranged pentanortriterpenoid derived from cycloartane. Isolated from the leaves and stem of Schisandra lancifolia, it exhibits anti-HIV activity. It has a role as a metabolite and an anti-HIV agent. It is an oxaspiro compound, a tetracyclic triterpenoid, a gamma-lactone, a diol and a monocarboxylic acid. A tetracyclic triterpenoid that is a rearranged pentanortriterpenoid derived from cycloartane. Isolated from the leaves and stem of Schisandra lancifolia, it exhibits anti-HIV activity.

   

20-Hydroxytingenone

20-Hydroxytingenone

C28H36O4 (436.2613456)


   
   
   
   

Azadirone

Azadirone

C28H36O4 (436.2613456)


A tetracyclic triterpenoid that is 4,4,8-trimethylandrosta-1,14-diene substituted by an oxo group at position 3, an acetoxy group at position 7 and a furan-3-yl group at position 17. Isolated from Azadirachta indica, it exhibits antiplasmodial and antineoplastic activities.

   
   
   
   
   
   
   
   

Inflexarabdonin A

Inflexarabdonin A

C24H36O7 (436.2460906)


   
   
   

Sargaol acetate

Sargaol acetate

C29H40O3 (436.297729)


   
   
   

22beta-Hydroxymaytenin

22beta-Hydroxymaytenin

C28H36O4 (436.2613456)


   
   

(ent-2alpha,3beta,13Z)-3-Angeloyloxy-8(17),13-labdadiene-2,15,16,18-tetrol

(ent-2alpha,3beta,13Z)-3-Angeloyloxy-8(17),13-labdadiene-2,15,16,18-tetrol

C25H40O6 (436.28247400000004)


   
   
   
   
   

N-{1-[4-(2-methoxyphenyl)piperazin-1-yl]propan-2-yl}-N-(pyridin-2-yl)cyclohexanecarboxamide

N-{1-[4-(2-methoxyphenyl)piperazin-1-yl]propan-2-yl}-N-(pyridin-2-yl)cyclohexanecarboxamide

C26H36N4O2 (436.2838116)


   

13-hydroxy-7-oxolabda-8,14-diene 13(R)-O-alpha-L-arabinopyranoside

13-hydroxy-7-oxolabda-8,14-diene 13(R)-O-alpha-L-arabinopyranoside

C25H40O6 (436.28247400000004)


   

cyclo-(alanyl->alanyl->prolyl->2-amino-9,10-epoxy-8-oxo-decanoyl)|cyclo<(2-amino-9,10-epoxy-8-oxodecanoyl)-alanyl-alanyl-prolyl>|HC-Totin

cyclo-(alanyl->alanyl->prolyl->2-amino-9,10-epoxy-8-oxo-decanoyl)|cyclo<(2-amino-9,10-epoxy-8-oxodecanoyl)-alanyl-alanyl-prolyl>|HC-Totin

C21H32N4O6 (436.2321732)


   
   

glyceryl mono-oleolyl-2-phosphate

glyceryl mono-oleolyl-2-phosphate

C21H41O7P (436.25897660000004)


   
   
   

6alpha,7beta-diacetoxy-13,14-dihydrokolavenic acid methyl ester

6alpha,7beta-diacetoxy-13,14-dihydrokolavenic acid methyl ester

C25H40O6 (436.28247400000004)


   
   

Me ester,20-Ac-beat-Cortolonic acid

Me ester,20-Ac-beat-Cortolonic acid

C24H36O7 (436.2460906)


   
   

1alpha,6beta,7beta,14beta-tetrahydroxy-20-isobutoxy-7alpha,20-epoxy-ent-kaur-16-en-15-one|hebeirubescensin D

1alpha,6beta,7beta,14beta-tetrahydroxy-20-isobutoxy-7alpha,20-epoxy-ent-kaur-16-en-15-one|hebeirubescensin D

C24H36O7 (436.2460906)


   
   
   

1alpha-isovaleryloxypolyachyrol

1alpha-isovaleryloxypolyachyrol

C24H36O7 (436.2460906)


   
   

9,10-epoxy-6alpha-O-tigloyl-7alphaH-8beta-O-(3-hydroxy-2-methylbutyryl)germacra-3(4)E-ene|trijugin H

9,10-epoxy-6alpha-O-tigloyl-7alphaH-8beta-O-(3-hydroxy-2-methylbutyryl)germacra-3(4)E-ene|trijugin H

C25H40O6 (436.28247400000004)


   

14,15-dihydroclerodin|clerodin|dihydroclerodin|dihydroclerodin-1|dihydroclerodin-I

14,15-dihydroclerodin|clerodin|dihydroclerodin|dihydroclerodin-1|dihydroclerodin-I

C24H36O7 (436.2460906)


   

hexadecane-1,16-diol 7-caffeoyl ester

hexadecane-1,16-diol 7-caffeoyl ester

C25H40O6 (436.28247400000004)


   
   

2,3-Dihydroxy-24,29-dinor-1,3,5(10),7-friedelatetraene-6,21-dione|6-oxotingenol

2,3-Dihydroxy-24,29-dinor-1,3,5(10),7-friedelatetraene-6,21-dione|6-oxotingenol

C28H36O4 (436.2613456)


   

briarellin D hydroperoxide

briarellin D hydroperoxide

C24H36O7 (436.2460906)


   

18-methylmalonyl-epi-methyltrineracetal

18-methylmalonyl-epi-methyltrineracetal

C25H40O6 (436.28247400000004)


   

2beta,3alpha-Dihydroxy-ent-labd-7-en-15-oic acid methyl ester diacetate

2beta,3alpha-Dihydroxy-ent-labd-7-en-15-oic acid methyl ester diacetate

C25H40O6 (436.28247400000004)


   

3beta,8alpha,13,14-erythro-tetrahydroxy-labda-15,17-dien-16,19-olide

3beta,8alpha,13,14-erythro-tetrahydroxy-labda-15,17-dien-16,19-olide

C25H40O6 (436.28247400000004)


   

12,13-Di-Ac-(4xi,6beta,9alpha,12xi,13xi)-2,10(18),14-Prenylguaiatriene-4,6,9,12,13-pentol

12,13-Di-Ac-(4xi,6beta,9alpha,12xi,13xi)-2,10(18),14-Prenylguaiatriene-4,6,9,12,13-pentol

C24H36O7 (436.2460906)


   

1alpha,3beta,15beta-trihydroxy-7beta,11beta-diacetoxy-ent-kaur-16-ene|nervonin H

1alpha,3beta,15beta-trihydroxy-7beta,11beta-diacetoxy-ent-kaur-16-ene|nervonin H

C24H36O7 (436.2460906)


   
   

16-(2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-17-nor-coryn-19-ene|4,17-dihydro 17 alpha-tchibangensine

16-(2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-17-nor-coryn-19-ene|4,17-dihydro 17 alpha-tchibangensine

C29H32N4 (436.26268319999997)


   

6alpha,11beta,15beta-trihydroxy-3beta,7beta-diacetoxy-ent-kaur-16-ene|xindongnin E

6alpha,11beta,15beta-trihydroxy-3beta,7beta-diacetoxy-ent-kaur-16-ene|xindongnin E

C24H36O7 (436.2460906)


   

methyl 7beta,15-diacetoxy-8-labden-17-oate

methyl 7beta,15-diacetoxy-8-labden-17-oate

C25H40O6 (436.28247400000004)


   

(22R)-4beta-hydroxy-1-oxo-witha-2,5,16,24-tetraenolide|(4S,20S,22R)-4-hydroxy-1-oxo-witha-2,5,16,24-tetraenolide

(22R)-4beta-hydroxy-1-oxo-witha-2,5,16,24-tetraenolide|(4S,20S,22R)-4-hydroxy-1-oxo-witha-2,5,16,24-tetraenolide

C28H36O4 (436.2613456)


   

12,13-Di-Ac-(3beta,6beta,9alpha,12xi,13xi)-4,10,14-Prenylguaiatriene-3,6,9,12,13-pentol

12,13-Di-Ac-(3beta,6beta,9alpha,12xi,13xi)-4,10,14-Prenylguaiatriene-3,6,9,12,13-pentol

C24H36O7 (436.2460906)


   

(2alpha,3alpha,7alpha,12?鈥?13?鈥?-3-(2-Methylbutanoyl):2,3,7-Trihydroxy-8(17)-labden-15,12-olide|2alpha,7alpha-dihydroxy-3alpha(2-methylbutanoyloxy)8(17)-labden-12,15-olide

(2alpha,3alpha,7alpha,12?鈥?13?鈥?-3-(2-Methylbutanoyl):2,3,7-Trihydroxy-8(17)-labden-15,12-olide|2alpha,7alpha-dihydroxy-3alpha(2-methylbutanoyloxy)8(17)-labden-12,15-olide

C25H40O6 (436.28247400000004)


   

19-(p-hydroxyhydrocinnamoyloxy)-ent-kaurenic acid|19--ent-kaurenic acid

19-(p-hydroxyhydrocinnamoyloxy)-ent-kaurenic acid|19--ent-kaurenic acid

C29H40O3 (436.297729)


   

6alpha-hydroxy-17-isovaleroxygrindelic acid

6alpha-hydroxy-17-isovaleroxygrindelic acid

C25H40O6 (436.28247400000004)


   
   

klymollin D

klymollin D

C24H36O7 (436.2460906)


An eunicellin diterpenoid isolated from the soft coral Klyxum molle.

   

12beta-O-acetyl-15alpha,28-dihydoxy-17beta-methoxy-3-oxo-20,21,22,23,24,25,26,27-octanordammanran

12beta-O-acetyl-15alpha,28-dihydoxy-17beta-methoxy-3-oxo-20,21,22,23,24,25,26,27-octanordammanran

C25H40O6 (436.28247400000004)


   

6alpha,8alpha,15(S),23-tetrahydroxy-labd-13(14),17-dien-16(S),19-olide

6alpha,8alpha,15(S),23-tetrahydroxy-labd-13(14),17-dien-16(S),19-olide

C25H40O6 (436.28247400000004)


   
   
   
   
   
   
   

(5S,8R,9S,10R,13S)-2-oxo-13-O-arabinopyranosyl-3,14-clerodadiene

(5S,8R,9S,10R,13S)-2-oxo-13-O-arabinopyranosyl-3,14-clerodadiene

C25H40O6 (436.28247400000004)


   
   
   

7alpha,14beta-dihydroxy-17alpha-ethoxymethyl-3beta-acetoxy-ent-kaur-11,15-dione

7alpha,14beta-dihydroxy-17alpha-ethoxymethyl-3beta-acetoxy-ent-kaur-11,15-dione

C24H36O7 (436.2460906)


   
   

3,3-dimethylundecan-2-yl 4-acetyl-2,3,6-trimethoxybenzoate|asiatoate A

3,3-dimethylundecan-2-yl 4-acetyl-2,3,6-trimethoxybenzoate|asiatoate A

C25H40O6 (436.28247400000004)


   

15-alpha-hydroxytingenone

15-alpha-hydroxytingenone

C28H36O4 (436.2613456)


   
   

20(S)-1alpha,6beta,7beta-trihydroxy-20-butoxy-8,15-seco-7alpha,20-epoxy-ent-kaur-16-en-11,15-olide|parvifoline Y

20(S)-1alpha,6beta,7beta-trihydroxy-20-butoxy-8,15-seco-7alpha,20-epoxy-ent-kaur-16-en-11,15-olide|parvifoline Y

C24H36O7 (436.2460906)


   

9,10-epoxy-5beta-O-tigloyl-7alphaH-6alpha,8beta-di-O-acetylgermacra-3(4)E-ene|trijugin B

9,10-epoxy-5beta-O-tigloyl-7alphaH-6alpha,8beta-di-O-acetylgermacra-3(4)E-ene|trijugin B

C24H36O7 (436.2460906)


   

15,16-diacetoxy-12,13-15,16-diepoxy-14-hydroxy-neoclerod-3-ene

15,16-diacetoxy-12,13-15,16-diepoxy-14-hydroxy-neoclerod-3-ene

C24H36O7 (436.2460906)


   
   
   

18-succinyloxygrindelic acid

18-succinyloxygrindelic acid

C24H36O7 (436.2460906)


   

3,9-dihydroxy-4,6a,6b,8a,11,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-dione

3,9-dihydroxy-4,6a,6b,8a,11,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-dione

C28H36O4 (436.2613456)


   

di-O-acetyllagohirsin

di-O-acetyllagohirsin

C24H36O7 (436.2460906)


   
   

(20S,22S,23R,24S)-14beta,22:22,25-diepoxy-23-hydroxyergosta-4,6,8,11-tetraen-3-one|blazeispirol U

(20S,22S,23R,24S)-14beta,22:22,25-diepoxy-23-hydroxyergosta-4,6,8,11-tetraen-3-one|blazeispirol U

C28H36O4 (436.2613456)


   

isoagatholal-15-O-beta-D-xylopyranoside

isoagatholal-15-O-beta-D-xylopyranoside

C25H40O6 (436.28247400000004)


   

9alpha,13alpha-diacetoxy-11(15->1)abeotaxa-4(20),11-diene-5alpha,10beta,15-triol

9alpha,13alpha-diacetoxy-11(15->1)abeotaxa-4(20),11-diene-5alpha,10beta,15-triol

C24H36O7 (436.2460906)


   

6alpha,7alpha-17beta-trihydroxy-15beta,17-oxidispongian-16-one 7-butyrate|aplyroseol-3

6alpha,7alpha-17beta-trihydroxy-15beta,17-oxidispongian-16-one 7-butyrate|aplyroseol-3

C24H36O7 (436.2460906)


   
   

(3aS,5R,5aS,6aS,7aS,8R,8aS,8bR)-dodecahydro-3a,8b-dihydroxy-5,7a-dimethyl-1-methylideneoxireno[6,7]naphtho[2,1-b]furan-8-yl decanoate|strobilol I

(3aS,5R,5aS,6aS,7aS,8R,8aS,8bR)-dodecahydro-3a,8b-dihydroxy-5,7a-dimethyl-1-methylideneoxireno[6,7]naphtho[2,1-b]furan-8-yl decanoate|strobilol I

C25H40O6 (436.28247400000004)


   
   
   
   

inflexarabdonin D

inflexarabdonin D

C24H36O7 (436.2460906)


   

6alpha-hydroxy-17-(alpha-methylbutyroxy)grindelic acid

6alpha-hydroxy-17-(alpha-methylbutyroxy)grindelic acid

C25H40O6 (436.28247400000004)


   

5alpha,13alpha-dihydroxy-9alpha,10beta-diacetoxy-11(15->1)-abeo-taxa-4(20),11-diene

5alpha,13alpha-dihydroxy-9alpha,10beta-diacetoxy-11(15->1)-abeo-taxa-4(20),11-diene

C24H36O7 (436.2460906)


   
   

methyl 3alpha,15-diacetoxy-labd-8(17)-en-19-oate

methyl 3alpha,15-diacetoxy-labd-8(17)-en-19-oate

C25H40O6 (436.28247400000004)


   

16-(2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-16-nor-coryn-3(14)-ene|3-Dehydrochrolifuanin|3-Dehydroochrolifuanin

16-(2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-16-nor-coryn-3(14)-ene|3-Dehydrochrolifuanin|3-Dehydroochrolifuanin

C29H32N4 (436.26268319999997)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Withasomniferolide A

Withasomniferolide A

C28H36O4 (436.2613456)


   

Withasomniferolide B

Withasomniferolide B

C28H36O4 (436.2613456)


   
   

Ala Ala Ile Tyr

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-methylpentanamido]-3-(4-hydroxyphenyl)propanoic acid

C21H32N4O6 (436.2321732)


   

Ala Ala Leu Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-4-methylpentanamido]-3-(4-hydroxyphenyl)propanoic acid

C21H32N4O6 (436.2321732)


   

Ala Ala Tyr Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylpentanoic acid

C21H32N4O6 (436.2321732)


   

Ala Ala Tyr Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-(4-hydroxyphenyl)propanamido]-4-methylpentanoic acid

C21H32N4O6 (436.2321732)


   

Ala Phe Ile Ser

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-phenylpropanamido]-3-methylpentanamido]-3-hydroxypropanoic acid

C21H32N4O6 (436.2321732)


   

Ala Phe Leu Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-phenylpropanamido]-4-methylpentanamido]-3-hydroxypropanoic acid

C21H32N4O6 (436.2321732)


   

Ala Phe Ser Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-phenylpropanamido]-3-hydroxypropanamido]-3-methylpentanoic acid

C21H32N4O6 (436.2321732)


   

Ala Phe Ser Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-phenylpropanamido]-3-hydroxypropanamido]-4-methylpentanoic acid

C21H32N4O6 (436.2321732)


   

Ala Phe Thr Val

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-phenylpropanamido]-3-hydroxybutanamido]-3-methylbutanoic acid

C21H32N4O6 (436.2321732)


   

Ala Phe Val Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-phenylpropanamido]-3-methylbutanamido]-3-hydroxybutanoic acid

C21H32N4O6 (436.2321732)


   

Ala His Ile Pro

(2S)-1-[(2S,3S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H32N6O5 (436.2434062)


   

Ala His Leu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H32N6O5 (436.2434062)


   

Ala His Pro Ile

(2S,3S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C20H32N6O5 (436.2434062)


   

Ala His Pro Leu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C20H32N6O5 (436.2434062)


   

Ala Ile Ala Tyr

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]propanamido]-3-(4-hydroxyphenyl)propanoic acid

C21H32N4O6 (436.2321732)


   

Ala Ile Phe Ser

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-3-phenylpropanamido]-3-hydroxypropanoic acid

C21H32N4O6 (436.2321732)


   

Ala Ile His Pro

(2S)-1-[(2S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoyl]pyrrolidine-2-carboxylic acid

C20H32N6O5 (436.2434062)


   

Ala Ile Pro His

(2S)-2-{[(2S)-1-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-(1H-imidazol-4-yl)propanoic acid

C20H32N6O5 (436.2434062)


   

Ala Ile Ser Phe

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-3-hydroxypropanamido]-3-phenylpropanoic acid

C21H32N4O6 (436.2321732)


   

Ala Ile Tyr Ala

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-3-(4-hydroxyphenyl)propanamido]propanoic acid

C21H32N4O6 (436.2321732)


   

Ala Leu Ala Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]propanamido]-3-(4-hydroxyphenyl)propanoic acid

C21H32N4O6 (436.2321732)


   

Ala Leu Phe Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-3-phenylpropanamido]-3-hydroxypropanoic acid

C21H32N4O6 (436.2321732)


   

Ala Leu His Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoyl]pyrrolidine-2-carboxylic acid

C20H32N6O5 (436.2434062)


   

Ala Leu Pro His

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-(1H-imidazol-4-yl)propanoic acid

C20H32N6O5 (436.2434062)


   

Ala Leu Ser Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-3-hydroxypropanamido]-3-phenylpropanoic acid

C21H32N4O6 (436.2321732)


   

Ala Leu Tyr Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-3-(4-hydroxyphenyl)propanamido]propanoic acid

C21H32N4O6 (436.2321732)


   

Ala Pro His Ile

(2S,3S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

C20H32N6O5 (436.2434062)


   

Ala Pro His Leu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

C20H32N6O5 (436.2434062)


   

Ala Pro Ile His

(2S)-2-[(2S,3S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C20H32N6O5 (436.2434062)


   

Ala Pro Leu His

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C20H32N6O5 (436.2434062)


   

Ala Ser Phe Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-3-phenylpropanamido]-3-methylpentanoic acid

C21H32N4O6 (436.2321732)


   

Ala Ser Phe Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-3-phenylpropanamido]-4-methylpentanoic acid

C21H32N4O6 (436.2321732)


   

Ala Ser Ile Phe

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-3-methylpentanamido]-3-phenylpropanoic acid

C21H32N4O6 (436.2321732)


   

Ala Ser Leu Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-4-methylpentanamido]-3-phenylpropanoic acid

C21H32N4O6 (436.2321732)


   

Ala Thr Phe Val

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanamido]-3-phenylpropanamido]-3-methylbutanoic acid

C21H32N4O6 (436.2321732)


   

Ala Thr Val Phe

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanamido]-3-methylbutanamido]-3-phenylpropanoic acid

C21H32N4O6 (436.2321732)


   

Ala Val Phe Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanamido]-3-phenylpropanamido]-3-hydroxybutanoic acid

C21H32N4O6 (436.2321732)


   

Ala Val Thr Phe

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanamido]-3-hydroxybutanamido]-3-phenylpropanoic acid

C21H32N4O6 (436.2321732)


   

Ala Tyr Ala Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(4-hydroxyphenyl)propanamido]propanamido]-3-methylpentanoic acid

C21H32N4O6 (436.2321732)


   

Ala Tyr Ala Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(4-hydroxyphenyl)propanamido]propanamido]-4-methylpentanoic acid

C21H32N4O6 (436.2321732)


   

Ala Tyr Ile Ala

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylpentanamido]propanoic acid

C21H32N4O6 (436.2321732)


   

Ala Tyr Leu Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(4-hydroxyphenyl)propanamido]-4-methylpentanamido]propanoic acid

C21H32N4O6 (436.2321732)


   

Phe Ala Ile Ser

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]propanamido]-3-methylpentanamido]-3-hydroxypropanoic acid

C21H32N4O6 (436.2321732)


   

Phe Ala Leu Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]propanamido]-4-methylpentanamido]-3-hydroxypropanoic acid

C21H32N4O6 (436.2321732)


   

Phe Ala Ser Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]propanamido]-3-hydroxypropanamido]-3-methylpentanoic acid

C21H32N4O6 (436.2321732)


   

Phe Ala Ser Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]propanamido]-3-hydroxypropanamido]-4-methylpentanoic acid

C21H32N4O6 (436.2321732)


   

Phe Ala Thr Val

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]propanamido]-3-hydroxybutanamido]-3-methylbutanoic acid

C21H32N4O6 (436.2321732)


   

Phe Ala Val Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]propanamido]-3-methylbutanamido]-3-hydroxybutanoic acid

C21H32N4O6 (436.2321732)


   

Phe Gly Ile Thr

(2S,3R)-2-[(2S,3S)-2-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}-3-methylpentanamido]-3-hydroxybutanoic acid

C21H32N4O6 (436.2321732)


   

Phe Gly Leu Thr

(2S,3R)-2-[(2S)-2-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}-4-methylpentanamido]-3-hydroxybutanoic acid

C21H32N4O6 (436.2321732)


   

Phe Gly Thr Ile

(2S,3S)-2-[(2S,3R)-2-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}-3-hydroxybutanamido]-3-methylpentanoic acid

C21H32N4O6 (436.2321732)


   

Phe Gly Thr Leu

(2S)-2-[(2S,3R)-2-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}-3-hydroxybutanamido]-4-methylpentanoic acid

C21H32N4O6 (436.2321732)


   

Phe Ile Ala Ser

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]propanamido]-3-hydroxypropanoic acid

C21H32N4O6 (436.2321732)


   

Phe Ile Gly Thr

(2S,3R)-2-{2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]acetamido}-3-hydroxybutanoic acid

C21H32N4O6 (436.2321732)


   

His Ala Ile Pro

(2S)-1-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H32N6O5 (436.2434062)


   

His Ala Leu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H32N6O5 (436.2434062)


   

His Ala Pro Ile

(2S,3S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C20H32N6O5 (436.2434062)


   

His Ala Pro Leu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C20H32N6O5 (436.2434062)


   

His Ile Ala Pro

(2S)-1-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]propanoyl]pyrrolidine-2-carboxylic acid

C20H32N6O5 (436.2434062)


   

His Ile Pro Ala

(2S)-2-{[(2S)-1-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C20H32N6O5 (436.2434062)


   

His Leu Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]propanoyl]pyrrolidine-2-carboxylic acid

C20H32N6O5 (436.2434062)


   

His Leu Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C20H32N6O5 (436.2434062)


   

His Pro Ala Ile

(2S,3S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl]formamido}propanamido]-3-methylpentanoic acid

C20H32N6O5 (436.2434062)


   

His Pro Ala Leu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl]formamido}propanamido]-4-methylpentanoic acid

C20H32N6O5 (436.2434062)


   

His Pro Ile Ala

(2S)-2-[(2S,3S)-2-{[(2S)-1-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanamido]propanoic acid

C20H32N6O5 (436.2434062)


   

His Pro Leu Ala

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]propanoic acid

C20H32N6O5 (436.2434062)


   

Ile Ala His Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]-3-(1H-imidazol-4-yl)propanoyl]pyrrolidine-2-carboxylic acid

C20H32N6O5 (436.2434062)


   

Ile Ala Pro His

(2S)-2-{[(2S)-1-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanoyl]pyrrolidin-2-yl]formamido}-3-(1H-imidazol-4-yl)propanoic acid

C20H32N6O5 (436.2434062)


   

Ile His Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]propanoyl]pyrrolidine-2-carboxylic acid

C20H32N6O5 (436.2434062)


   

Ile His Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C20H32N6O5 (436.2434062)


   

Ile Pro Ala His

(2S)-2-[(2S)-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C20H32N6O5 (436.2434062)


   

Ile Pro His Ala

(2S)-2-[(2S)-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C20H32N6O5 (436.2434062)


   

Leu Ala His Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]-3-(1H-imidazol-4-yl)propanoyl]pyrrolidine-2-carboxylic acid

C20H32N6O5 (436.2434062)


   

Leu Ala Pro His

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanoyl]pyrrolidin-2-yl]formamido}-3-(1H-imidazol-4-yl)propanoic acid

C20H32N6O5 (436.2434062)


   

Leu His Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]propanoyl]pyrrolidine-2-carboxylic acid

C20H32N6O5 (436.2434062)


   

Leu His Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C20H32N6O5 (436.2434062)


   
   
   

Leu Pro Ala His

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C20H32N6O5 (436.2434062)


   

Leu Pro His Ala

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C20H32N6O5 (436.2434062)


   

Pro Ala His Ile

(2S,3S)-2-[(2S)-3-(1H-imidazol-4-yl)-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]-3-methylpentanoic acid

C20H32N6O5 (436.2434062)


   

Pro Ala His Leu

(2S)-2-[(2S)-3-(1H-imidazol-4-yl)-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]-4-methylpentanoic acid

C20H32N6O5 (436.2434062)


   

Pro Ala Ile His

(2S)-3-(1H-imidazol-4-yl)-2-[(2S,3S)-3-methyl-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]pentanamido]propanoic acid

C20H32N6O5 (436.2434062)


   

Pro Ala Leu His

(2S)-3-(1H-imidazol-4-yl)-2-[(2S)-4-methyl-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]pentanamido]propanoic acid

C20H32N6O5 (436.2434062)


   

Pro His Ala Ile

(2S,3S)-2-[(2S)-2-[(2S)-3-(1H-imidazol-4-yl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]-3-methylpentanoic acid

C20H32N6O5 (436.2434062)


   

Pro His Ala Leu

(2S)-2-[(2S)-2-[(2S)-3-(1H-imidazol-4-yl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]-4-methylpentanoic acid

C20H32N6O5 (436.2434062)


   

Pro His Ile Ala

(2S)-2-[(2S,3S)-2-[(2S)-3-(1H-imidazol-4-yl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-methylpentanamido]propanoic acid

C20H32N6O5 (436.2434062)


   

Pro His Leu Ala

(2S)-2-[(2S)-2-[(2S)-3-(1H-imidazol-4-yl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-4-methylpentanamido]propanoic acid

C20H32N6O5 (436.2434062)


   

Pro Ile Ala His

(2S)-3-(1H-imidazol-4-yl)-2-[(2S)-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanamido]propanoic acid

C20H32N6O5 (436.2434062)


   

Pro Ile His Ala

(2S)-2-[(2S)-3-(1H-imidazol-4-yl)-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanamido]propanoic acid

C20H32N6O5 (436.2434062)


   

Pro Leu Ala His

(2S)-3-(1H-imidazol-4-yl)-2-[(2S)-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanamido]propanoic acid

C20H32N6O5 (436.2434062)


   

Pro Leu His Ala

(2S)-2-[(2S)-3-(1H-imidazol-4-yl)-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanamido]propanoic acid

C20H32N6O5 (436.2434062)


   
   

Simvastatin acid

Simvastatin acid

C25H40O6 (436.28247400000004)


C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent C471 - Enzyme Inhibitor > C1655 - HMG-CoA Reductase Inhibitor

   
   

PA(18:1/0:0)

9-Octadecenoic acid (Z)-, 2-hydroxy-3-(phosphonooxy)propyl ester, (R)-

C21H41O7P (436.25897660000004)


   

Oleoyl lysophosphatidic acid

1-(9Z-octadecenoyl)-sn-glycero-3-phosphate

C21H41O7P (436.25897660000004)


   

(5Z,7E)-(1S,3R)-24-methylsulfonyl-9,10-seco-5,7,10(19)-cholatriene-1,3-diol

1α-hydroxy-24-methylsulfonyl-25,26,27-trinorvitamin D3 / 1α-hydroxy-24-methylsulfonyl-25,26,27-trinorcholecalciferol

C25H40O4S (436.2647160000001)


   

LysoPA(18:1)

2-(9Z-octadecenoyl)-sn-glycero-3-phosphate

C21H41O7P (436.25897660000004)


   
   

1-Oleoyl Lysophosphatidic Acid (sodium salt)

1-O-9Z-octadecenoyl-sn-glyceryl-3-phosphoric acid, sodium salt

C21H41O7P (436.25897660000004)


   

Vitamin B15

6-({2,2-bis[bis(propan-2-yl)amino]acetyl}oxy)-2,3,4,5-tetrahydroxyhexanoic acid

C20H40N2O8 (436.278452)


   

(R)-1-O-[b-D-Apiofuranosyl-(1->2)-b-D-glucopyranoside]-1,3-octanediol

3-{[3-hydroxy-4-(hydroxymethyl)-4-methyloxolan-2-yl]oxy}-6-(hydroxymethyl)-2-[(3-hydroxyoctyl)oxy]-5-methyloxan-4-ol

C21H40O9 (436.26721900000007)


   

LPA 18:1

9-Octadecenoic acid (Z)-, 2-hydroxy-3-(phosphonooxy)propyl ester, (R)-

C21H41O7P (436.25897660000004)


   

ST 28:6;O3

(22R)-3,26-Dioxo-22,26-epoxyergosta-1,4,24-trien-18-al

C28H36O4 (436.2613456)


   

1alpha-hydroxy-24-methylsulfonyl-25,26,27-trinorvitamin D3

(5Z,7E)-(1S,3R)-24-methylsulfonyl-9,10-seco-5,7,10(19)-cholatriene-1,3-diol

C25H40O4S (436.2647160000001)


   

N-[2-[4-(2-METHOXYPHENYL)PIPERAZINO]-1-METHYLETHYL]-N-PYRIDIN-2-YLCYCLOHEXANECARBOXAMIDE

N-[2-[4-(2-METHOXYPHENYL)PIPERAZINO]-1-METHYLETHYL]-N-PYRIDIN-2-YLCYCLOHEXANECARBOXAMIDE

C26H36N4O2 (436.2838116)


   
   

Bolmantalate

[(8R,9S,10R,13S,14S,17S)-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] adamantane-1-carboxylate

C29H40O3 (436.297729)


C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone

   
   

Lifarizine

Lifarizine

C29H32N4 (436.26268319999997)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker C93038 - Cation Channel Blocker

   
   

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-trityl-1H-pyrazole

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-trityl-1H-pyrazole

C28H29BN2O2 (436.23219639999996)


   

4-Pentyloxyphenyl-4-Trans-PentylcyclohexylBenzo

4-Pentyloxyphenyl-4-Trans-PentylcyclohexylBenzo

C29H40O3 (436.297729)


   

2-Dicyclohexylphosphino-2,6-bis(N,N-dimethylamino)biphenyl

2-Dicyclohexylphosphino-2,6-bis(N,N-dimethylamino)biphenyl

C28H41N2P (436.30071960000004)


   

BIS(4-(VINYLOXYMETHYL)CYCLOHEXYLMETHYL)&

BIS(4-(VINYLOXYMETHYL)CYCLOHEXYLMETHYL)&

C25H40O6 (436.28247400000004)


   

FGIN-1-27

N,N-Dihexyl-2-(4-fluorophenyl)indole-3-acetamide

C28H37FN2O (436.28897639999997)


D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids

   

(trans,trans)-4-Pentyl-[1,1-bicyclohexyl]-4-carboxylic acid 4-ethoxy-2,3-difluorophenyl ester

(trans,trans)-4-Pentyl-[1,1-bicyclohexyl]-4-carboxylic acid 4-ethoxy-2,3-difluorophenyl ester

C26H38F2O3 (436.2788862)


   

1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-[7-[[2-(triMethylsilyl)ethoxy]Methyl]-7H-pyrrolo[2,3-d]pyriMidin-4-yl]-, (βR)-

1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-[7-[[2-(triMethylsilyl)ethoxy]Methyl]-7H-pyrrolo[2,3-d]pyriMidin-4-yl]-, (βR)-

C23H32N6OSi (436.24067419999994)


   

dodecyl 2-methylprop-2-enoate,3,3,3-trifluoropropyl 2-methylprop-2-enoate

dodecyl 2-methylprop-2-enoate,3,3,3-trifluoropropyl 2-methylprop-2-enoate

C23H39F3O4 (436.280029)


   

Cipemastat

Cipemastat

C22H36N4O5 (436.2685566)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D061965 - Matrix Metalloproteinase Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C1970 - Matrix Metalloproteinase Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor

   
   

Dimethyl-amino-acetylgluconic acid

Dimethyl-amino-acetylgluconic acid

C20H40N2O8 (436.278452)


   
   

N~2~-1,3-Benzoxazol-2-YL-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-L-alaninamide

N~2~-1,3-Benzoxazol-2-YL-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-L-alaninamide

C25H32N4O3 (436.24742819999994)


   

pangamic acid

(2R,3S,4R,5R)-6-[2,2-bis(di(propan-2-yl)amino)ethanoyloxy]-2,3,4,5-tetrahydroxy-hexanoic acid

C20H40N2O8 (436.278452)


   

1-Stearoyl-sn-glycero-3-phosphate(2-)

1-Stearoyl-sn-glycero-3-phosphate(2-)

C21H41O7P-2 (436.25897660000004)


   

(2S)-2-azaniumyl-5-[[(2R)-1-[[2-[4-(3-azaniumylpropylazaniumyl)butylamino]-2-oxoethyl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoate

(2S)-2-azaniumyl-5-[[(2R)-1-[[2-[4-(3-azaniumylpropylazaniumyl)butylamino]-2-oxoethyl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoate

C17H36N6O5S+2 (436.24677660000003)


   
   

[(2R)-2-hydroxy-3-phosphonooxypropyl] (E)-octadec-11-enoate

[(2R)-2-hydroxy-3-phosphonooxypropyl] (E)-octadec-11-enoate

C21H41O7P (436.25897660000004)


   

[(2R)-2-hydroxy-3-phosphonooxypropyl] (Z)-octadec-11-enoate

[(2R)-2-hydroxy-3-phosphonooxypropyl] (Z)-octadec-11-enoate

C21H41O7P (436.25897660000004)


   

3-[2-[(3S,5R,8R,9S,10S,13R,14S,17S)-3,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-3-oxopropanoic acid

3-[2-[(3S,5R,8R,9S,10S,13R,14S,17S)-3,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-3-oxopropanoic acid

C24H36O7 (436.2460906)


   

DG(2:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

DG(2:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

C25H40O6 (436.28247400000004)


   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/2:0/0:0)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/2:0/0:0)

C25H40O6 (436.28247400000004)


   

DG(2:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

DG(2:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

C25H40O6 (436.28247400000004)


   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/2:0)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/2:0)

C25H40O6 (436.28247400000004)


   

DG(2:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

DG(2:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

C25H40O6 (436.28247400000004)


   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/2:0/0:0)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/2:0/0:0)

C25H40O6 (436.28247400000004)


   

DG(2:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

DG(2:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

C25H40O6 (436.28247400000004)


   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/2:0)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/2:0)

C25H40O6 (436.28247400000004)


   

DG(2:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

DG(2:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

C25H40O6 (436.28247400000004)


   

DG(20:3(5Z,11Z,14Z)-O(8,9)/2:0/0:0)

DG(20:3(5Z,11Z,14Z)-O(8,9)/2:0/0:0)

C25H40O6 (436.28247400000004)


   

DG(2:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

DG(2:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

C25H40O6 (436.28247400000004)


   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/2:0)

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/2:0)

C25H40O6 (436.28247400000004)


   

DG(2:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

DG(2:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

C25H40O6 (436.28247400000004)


   

DG(20:3(8Z,11Z,14Z)-O(5,6)/2:0/0:0)

DG(20:3(8Z,11Z,14Z)-O(5,6)/2:0/0:0)

C25H40O6 (436.28247400000004)


   

DG(2:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

DG(2:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

C25H40O6 (436.28247400000004)


   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/2:0)

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/2:0)

C25H40O6 (436.28247400000004)


   

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

C25H40O6 (436.28247400000004)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/2:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/2:0/0:0)

C25H40O6 (436.28247400000004)


   

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

C25H40O6 (436.28247400000004)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/2:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/2:0)

C25H40O6 (436.28247400000004)


   

DG(2:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

DG(2:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

C25H40O6 (436.28247400000004)


   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/2:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/2:0/0:0)

C25H40O6 (436.28247400000004)


   

DG(2:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

DG(2:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

C25H40O6 (436.28247400000004)


   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/2:0)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/2:0)

C25H40O6 (436.28247400000004)


   

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

C25H40O6 (436.28247400000004)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/2:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/2:0/0:0)

C25H40O6 (436.28247400000004)


   

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

C25H40O6 (436.28247400000004)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/2:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/2:0)

C25H40O6 (436.28247400000004)


   

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

C25H40O6 (436.28247400000004)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/2:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/2:0/0:0)

C25H40O6 (436.28247400000004)


   

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

C25H40O6 (436.28247400000004)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/2:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/2:0)

C25H40O6 (436.28247400000004)


   

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

C25H40O6 (436.28247400000004)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/2:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/2:0/0:0)

C25H40O6 (436.28247400000004)


   

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

C25H40O6 (436.28247400000004)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/2:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/2:0)

C25H40O6 (436.28247400000004)


   

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

C25H40O6 (436.28247400000004)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/2:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/2:0/0:0)

C25H40O6 (436.28247400000004)


   

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

C25H40O6 (436.28247400000004)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/2:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/2:0)

C25H40O6 (436.28247400000004)


   

DG(2:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

DG(2:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

C25H40O6 (436.28247400000004)


   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/2:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/2:0/0:0)

C25H40O6 (436.28247400000004)


   

DG(2:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

DG(2:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

C25H40O6 (436.28247400000004)


   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/2:0)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/2:0)

C25H40O6 (436.28247400000004)


   

DG(2:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

DG(2:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

C25H40O6 (436.28247400000004)


   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/2:0/0:0)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/2:0/0:0)

C25H40O6 (436.28247400000004)


   

DG(2:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

DG(2:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

C25H40O6 (436.28247400000004)


   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/2:0)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/2:0)

C25H40O6 (436.28247400000004)


   

DG(2:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

DG(2:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

C25H40O6 (436.28247400000004)


   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/2:0/0:0)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/2:0/0:0)

C25H40O6 (436.28247400000004)


   

DG(2:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

DG(2:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

C25H40O6 (436.28247400000004)


   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/2:0)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/2:0)

C25H40O6 (436.28247400000004)


   

DG(2:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

DG(2:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

C25H40O6 (436.28247400000004)


   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/2:0/0:0)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/2:0/0:0)

C25H40O6 (436.28247400000004)


   

DG(2:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

DG(2:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

C25H40O6 (436.28247400000004)


   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/2:0)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/2:0)

C25H40O6 (436.28247400000004)


   

14,15-Dihydroclerodin

14,15-Dihydroclerodin

C24H36O7 (436.2460906)


A diterpenoid isolated from the aerial parts of Ajuga bracteosa and has been shown to exhibit antifeedant activity.

   
   

3-[3,5-dimethyl-1-[6-(1-piperidinyl)-3-pyridazinyl]-4-pyrazolyl]-N-(3-fluoro-4-methylphenyl)propanamide

3-[3,5-dimethyl-1-[6-(1-piperidinyl)-3-pyridazinyl]-4-pyrazolyl]-N-(3-fluoro-4-methylphenyl)propanamide

C24H29FN6O (436.23867559999997)


   

1-(1-Piperidinyl)-3-[4-[[2-[4-(trifluoromethyl)phenyl]ethylamino]methyl]phenoxy]-2-propanol

1-(1-Piperidinyl)-3-[4-[[2-[4-(trifluoromethyl)phenyl]ethylamino]methyl]phenoxy]-2-propanol

C24H31F3N2O2 (436.2337502)


   

1-Palmityl-2-acetyl-sn-glycero-3-phosphate(2-)

1-Palmityl-2-acetyl-sn-glycero-3-phosphate(2-)

C21H41O7P-2 (436.25897660000004)


   

N-[2-(cyclopentylamino)-2-oxoethyl]-N-(3,4-dimethylphenyl)-N-(2-pyridinyl)pentanediamide

N-[2-(cyclopentylamino)-2-oxoethyl]-N-(3,4-dimethylphenyl)-N-(2-pyridinyl)pentanediamide

C25H32N4O3 (436.24742819999994)


   

6,8-dimethyl-3-[(3-methyl-1-piperidinyl)-[1-(2-oxolanylmethyl)-5-tetrazolyl]methyl]-1H-quinolin-2-one

6,8-dimethyl-3-[(3-methyl-1-piperidinyl)-[1-(2-oxolanylmethyl)-5-tetrazolyl]methyl]-1H-quinolin-2-one

C24H32N6O2 (436.25866119999995)


   

N-[2-(cyclopentylamino)-2-oxoethyl]-N-(4-methoxyphenyl)-6-(1-piperidinyl)-3-pyridinecarboxamide

N-[2-(cyclopentylamino)-2-oxoethyl]-N-(4-methoxyphenyl)-6-(1-piperidinyl)-3-pyridinecarboxamide

C25H32N4O3 (436.24742819999994)


   
   
   
   

2-[(3R,6aR,8R,10aR)-3-hydroxy-1-(3,3,3-trifluoropropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(cyclohexylmethyl)acetamide

2-[(3R,6aR,8R,10aR)-3-hydroxy-1-(3,3,3-trifluoropropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(cyclohexylmethyl)acetamide

C21H35F3N2O4 (436.25487860000004)


   

2-[(3S,6aR,8R,10aR)-3-hydroxy-1-(3,3,3-trifluoropropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(cyclohexylmethyl)acetamide

2-[(3S,6aR,8R,10aR)-3-hydroxy-1-(3,3,3-trifluoropropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(cyclohexylmethyl)acetamide

C21H35F3N2O4 (436.25487860000004)


   

2-[(3R,6aR,8S,10aR)-3-hydroxy-1-(3,3,3-trifluoropropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(cyclohexylmethyl)acetamide

2-[(3R,6aR,8S,10aR)-3-hydroxy-1-(3,3,3-trifluoropropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(cyclohexylmethyl)acetamide

C21H35F3N2O4 (436.25487860000004)


   

(10S,11S)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one

(10S,11S)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one

C27H36N2O3 (436.2725786)


   

(10S,11R)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one

(10S,11R)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one

C27H36N2O3 (436.2725786)


   

2-[(3S,6aS,8S,10aS)-3-hydroxy-1-(3,3,3-trifluoropropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(cyclohexylmethyl)acetamide

2-[(3S,6aS,8S,10aS)-3-hydroxy-1-(3,3,3-trifluoropropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(cyclohexylmethyl)acetamide

C21H35F3N2O4 (436.25487860000004)


   

2-[(3S,6aS,8R,10aS)-3-hydroxy-1-(3,3,3-trifluoropropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(cyclohexylmethyl)acetamide

2-[(3S,6aS,8R,10aS)-3-hydroxy-1-(3,3,3-trifluoropropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(cyclohexylmethyl)acetamide

C21H35F3N2O4 (436.25487860000004)


   

(10S,11S)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one

(10S,11S)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one

C27H36N2O3 (436.2725786)


   

(10R,11S)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one

(10R,11S)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one

C27H36N2O3 (436.2725786)


   

2-[(3R,6aS,8S,10aS)-3-hydroxy-1-(3,3,3-trifluoropropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(cyclohexylmethyl)acetamide

2-[(3R,6aS,8S,10aS)-3-hydroxy-1-(3,3,3-trifluoropropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(cyclohexylmethyl)acetamide

C21H35F3N2O4 (436.25487860000004)


   

2-[(3S,6aR,8S,10aR)-3-hydroxy-1-(3,3,3-trifluoropropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(cyclohexylmethyl)acetamide

2-[(3S,6aR,8S,10aR)-3-hydroxy-1-(3,3,3-trifluoropropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(cyclohexylmethyl)acetamide

C21H35F3N2O4 (436.25487860000004)


   

(2S,3S,3aR,9bR)-N-(cyclohexylmethyl)-3-(hydroxymethyl)-1-methyl-6-oxo-7-(3-pyridinyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

(2S,3S,3aR,9bR)-N-(cyclohexylmethyl)-3-(hydroxymethyl)-1-methyl-6-oxo-7-(3-pyridinyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C25H32N4O3 (436.24742819999994)


   

(2R,3R,3aS,9bS)-N-(cyclohexylmethyl)-3-(hydroxymethyl)-1-methyl-6-oxo-7-(3-pyridinyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

(2R,3R,3aS,9bS)-N-(cyclohexylmethyl)-3-(hydroxymethyl)-1-methyl-6-oxo-7-(3-pyridinyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C25H32N4O3 (436.24742819999994)


   

4-[(3aR,4R,9bR)-1-[2-(dimethylamino)-1-oxoethyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide

4-[(3aR,4R,9bR)-1-[2-(dimethylamino)-1-oxoethyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide

C25H32N4O3 (436.24742819999994)


   

(10R,11S)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one

(10R,11S)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one

C27H36N2O3 (436.2725786)


   

(10R,11R)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one

(10R,11R)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one

C27H36N2O3 (436.2725786)


   
   
   

2-[(E)-5-[(1R,2R,4S,5S,6R,8aS)-2,4,6-trihydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-3-methylpent-2-enyl]-3-methyl-2H-uran-5-one

2-[(E)-5-[(1R,2R,4S,5S,6R,8aS)-2,4,6-trihydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-3-methylpent-2-enyl]-3-methyl-2H-uran-5-one

C25H40O6 (436.28247400000004)


   
   
   
   

[(E)-2-(hexanoylamino)-3-hydroxynon-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(hexanoylamino)-3-hydroxynon-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C20H41N2O6P (436.27020960000004)


   

[(E)-2-acetamido-3-hydroxytridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-acetamido-3-hydroxytridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C20H41N2O6P (436.27020960000004)


   

[(E)-3-hydroxy-2-(pentanoylamino)dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(pentanoylamino)dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C20H41N2O6P (436.27020960000004)


   

[(E)-3-hydroxy-2-(propanoylamino)dodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(propanoylamino)dodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C20H41N2O6P (436.27020960000004)


   

[(E)-2-(butanoylamino)-3-hydroxyundec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(butanoylamino)-3-hydroxyundec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C20H41N2O6P (436.27020960000004)


   

[(E)-2-(heptanoylamino)-3-hydroxyoct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(heptanoylamino)-3-hydroxyoct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C20H41N2O6P (436.27020960000004)


   

3,4 Dimethyl-6-(2-methylphenyl)-6-phenyl-1,1-bis(trimethlsilyl)-1-silacyclohex-3-ene

3,4 Dimethyl-6-(2-methylphenyl)-6-phenyl-1,1-bis(trimethlsilyl)-1-silacyclohex-3-ene

C26H40Si3 (436.24376800000005)


   
   

1-Oleoyl-sn-glycerol 3-phosphate

1-Oleoyl-sn-glycerol 3-phosphate

C21H41O7P (436.25897660000004)


A 1-acyl-sn-glycerol 3-phosphate having oleoyl as the 1-O-acyl group.

   

1-Stearoyl-sn-glycero-3-phosphate(2-)

1-Stearoyl-sn-glycero-3-phosphate(2-)

C21H41O7P (436.25897660000004)


A 1-acyl-sn-glycerol 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-stearoyl-sn-glycero-3-phosphate.

   
   

2-hydroxy-3-(phosphonooxy)propyl octadec-9-enoate

2-hydroxy-3-(phosphonooxy)propyl octadec-9-enoate

C21H41O7P (436.25897660000004)


   

6-[2,2-Bis[di(propan-2-yl)amino]acetyl]oxy-2,3,4,5-tetrahydroxyhexanoic acid

6-[2,2-Bis[di(propan-2-yl)amino]acetyl]oxy-2,3,4,5-tetrahydroxyhexanoic acid

C20H40N2O8 (436.278452)


   

Paraminabeolide A

Paraminabeolide A

C28H36O4 (436.2613456)


A withanolide that is 22,26-epoxyergosta-1,4,24-triene-18-al substituted by oxo groups at positions 3 and 26. Isolated from a Formosan soft coral, Paraminabea acronocephala, it exhibits cytotoxic activity.

   

2-oleoyl-sn-glycero-3-phosphate

2-oleoyl-sn-glycero-3-phosphate

C21H41O7P (436.25897660000004)


A 2-acyl-sn-glycerol 3-phosphate in which the phosphatidyl acyl group is specified as oleoyl.

   

1-Palmityl-2-acetyl-sn-glycero-3-phosphate(2-)

1-Palmityl-2-acetyl-sn-glycero-3-phosphate(2-)

C21H41O7P (436.25897660000004)


A 1-alkyl-2-acyl-sn-glycero-3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-palmityl-2-acetyl-sn-glycero-3-phosphate; major species at pH 7.3.

   
   

1-octadec-9-enoylglycero-3-phosphate

1-octadec-9-enoylglycero-3-phosphate

C21H41O7P (436.25897660000004)


   

Glutathionylspermidinium(2+)

Glutathionylspermidinium(2+)

C17H36N6O5S (436.24677660000003)


Dication of glutathionylspermidine arising from deprotonation of the terminal carboxy group and protonation of the primary and secondary amino groups; major species at pH 7.3.

   

TG(22:3)

TG(4:0_6:0_12:3)

C25H40O6 (436.28247400000004)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

LPEt(16:1)

LPEt(16:1)

C21H41O7P (436.25897660000004)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

FAHFA 10:3/O-18:6

FAHFA 10:3/O-18:6

C28H36O4 (436.2613456)


   

FAHFA 12:4/O-16:5

FAHFA 12:4/O-16:5

C28H36O4 (436.2613456)


   

FAHFA 13:4/O-15:5

FAHFA 13:4/O-15:5

C28H36O4 (436.2613456)


   

FAHFA 15:5/O-13:4

FAHFA 15:5/O-13:4

C28H36O4 (436.2613456)


   

FAHFA 16:5/O-12:4

FAHFA 16:5/O-12:4

C28H36O4 (436.2613456)


   

FAHFA 18:6/O-10:3

FAHFA 18:6/O-10:3

C28H36O4 (436.2613456)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(1s,3br,4r,5ar,9ar,9br,11as)-1-(furan-3-yl)-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

(1s,3br,4r,5ar,9ar,9br,11as)-1-(furan-3-yl)-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

C28H36O4 (436.2613456)


   

(2r,3s,4r,5r)-6-{[2,2-bis(diisopropylamino)acetyl]oxy}-2,3,4,5-tetrahydroxyhexanoic acid

(2r,3s,4r,5r)-6-{[2,2-bis(diisopropylamino)acetyl]oxy}-2,3,4,5-tetrahydroxyhexanoic acid

C20H40N2O8 (436.278452)


   

[8-(acetyloxy)-5-(1,3-dihydroxy-3-methylpent-4-en-1-yl)-1,5,6-trimethyl-2-oxo-4,6,7,8-tetrahydro-3h-naphthalen-1-yl]methyl acetate

[8-(acetyloxy)-5-(1,3-dihydroxy-3-methylpent-4-en-1-yl)-1,5,6-trimethyl-2-oxo-4,6,7,8-tetrahydro-3h-naphthalen-1-yl]methyl acetate

C24H36O7 (436.2460906)


   

3,18-dihydroxy-5,5,9-trimethyl-14-oxo-15,17-dioxapentacyclo[11.5.1.0¹,¹⁰.0⁴,⁹.0¹⁶,¹⁹]nonadecan-2-yl butanoate

3,18-dihydroxy-5,5,9-trimethyl-14-oxo-15,17-dioxapentacyclo[11.5.1.0¹,¹⁰.0⁴,⁹.0¹⁶,¹⁹]nonadecan-2-yl butanoate

C24H36O7 (436.2460906)


   

(2r,3r,4s,6r,7s)-2-{[(1s,2r,4ar,8ar)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]methyl}-4-(acetyloxy)-7-hydroxy-1,5-dioxaspiro[2.4]heptan-6-yl acetate

(2r,3r,4s,6r,7s)-2-{[(1s,2r,4ar,8ar)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]methyl}-4-(acetyloxy)-7-hydroxy-1,5-dioxaspiro[2.4]heptan-6-yl acetate

C24H36O7 (436.2460906)


   

2-[(1as,2r,2as,3r,5's,6ar,7s,7as)-3,7-dihydroxy-1a,2a,5',6,6-pentamethyl-hexahydrospiro[naphtho[2,3-b]oxirene-2,2'-oxolan]-5'-yl]ethyl 3-methylbut-2-enoate

2-[(1as,2r,2as,3r,5's,6ar,7s,7as)-3,7-dihydroxy-1a,2a,5',6,6-pentamethyl-hexahydrospiro[naphtho[2,3-b]oxirene-2,2'-oxolan]-5'-yl]ethyl 3-methylbut-2-enoate

C25H40O6 (436.28247400000004)


   

2,3-dimethoxy-5-methyl-6-[(2e,6z,9e)-3,7,9-trimethyl-11-phenylundeca-2,6,9-trien-1-yl]pyran-4-one

2,3-dimethoxy-5-methyl-6-[(2e,6z,9e)-3,7,9-trimethyl-11-phenylundeca-2,6,9-trien-1-yl]pyran-4-one

C28H36O4 (436.2613456)


   

ethyl (3r,5r)-7-[(1s,2s,8s,8ar)-2-methyl-8-{[(2s)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate

ethyl (3r,5r)-7-[(1s,2s,8s,8ar)-2-methyl-8-{[(2s)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate

C25H40O6 (436.28247400000004)


   

(1'r,2s,3r,4s,10's,14'r,15'r,16's)-3-hydroxy-4,5,5,10',14',16'-hexamethyl-18'-oxaspiro[oxolane-2,17'-pentacyclo[13.3.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosane]-2'(11'),3',5',12'-tetraen-7'-one

(1'r,2s,3r,4s,10's,14'r,15'r,16's)-3-hydroxy-4,5,5,10',14',16'-hexamethyl-18'-oxaspiro[oxolane-2,17'-pentacyclo[13.3.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosane]-2'(11'),3',5',12'-tetraen-7'-one

C28H36O4 (436.2613456)


   

1-[1-(4,5-dihydroxy-3-methylidenepentyl)-1,4a,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-2-yl]methyl 4-methyl butanedioate

1-[1-(4,5-dihydroxy-3-methylidenepentyl)-1,4a,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-2-yl]methyl 4-methyl butanedioate

C25H40O6 (436.28247400000004)


   

{5-[(acetyloxy)methyl]-1-[2-(5-methoxyoxolan-3-yl)ethyl]-1,2-dimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl}methyl acetate

{5-[(acetyloxy)methyl]-1-[2-(5-methoxyoxolan-3-yl)ethyl]-1,2-dimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl}methyl acetate

C25H40O6 (436.28247400000004)


   

(1s,2s,4r,6s,8s,9r,10s,11s,13s,15r)-6-(acetyloxy)-8,11,15-trihydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-2-yl acetate

(1s,2s,4r,6s,8s,9r,10s,11s,13s,15r)-6-(acetyloxy)-8,11,15-trihydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-2-yl acetate

C24H36O7 (436.2460906)


   

6-(acetyloxy)-3,8,11-trihydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl acetate

6-(acetyloxy)-3,8,11-trihydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl acetate

C24H36O7 (436.2460906)


   

(1r,5r,8r)-8-[(1r,3as,3bs,9ar,9bs,11as)-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

(1r,5r,8r)-8-[(1r,3as,3bs,9ar,9bs,11as)-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

C28H36O4 (436.2613456)


   

(2r)-2,8-dimethyl-2-[(3e,7e)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]chromen-6-yl acetate

(2r)-2,8-dimethyl-2-[(3e,7e)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]chromen-6-yl acetate

C29H40O3 (436.297729)


   

(1s,3s,4r,6s,8s,9s,10r,11s,13s,15r)-6-(acetyloxy)-8,11,15-trihydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-3-yl acetate

(1s,3s,4r,6s,8s,9s,10r,11s,13s,15r)-6-(acetyloxy)-8,11,15-trihydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-3-yl acetate

C24H36O7 (436.2460906)


   

(1r,5s,7r)-7-[(1s,3as,3bs,9ar,9bs,11as)-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

(1r,5s,7r)-7-[(1s,3as,3bs,9ar,9bs,11as)-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

C28H36O4 (436.2613456)


   

(1r,3bs,4r,5ar,9as,9bs,11as)-1-(furan-3-yl)-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

(1r,3bs,4r,5ar,9as,9bs,11as)-1-(furan-3-yl)-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

C28H36O4 (436.2613456)


   

(1r,3s,4r,6s,8s,9r,10r,11s,13s,15r)-6-(acetyloxy)-3,8,11-trihydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl acetate

(1r,3s,4r,6s,8s,9r,10r,11s,13s,15r)-6-(acetyloxy)-3,8,11-trihydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl acetate

C24H36O7 (436.2460906)


   

1,16-dihydroxyhexadecan-7-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

1,16-dihydroxyhexadecan-7-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C25H40O6 (436.28247400000004)


   

(1s,2s,3s,4s,5s,6e,10r)-2,4-bis(acetyloxy)-3-isopropyl-6,10-dimethyl-11-oxabicyclo[8.1.0]undec-6-en-5-yl (2e)-2-methylbut-2-enoate

(1s,2s,3s,4s,5s,6e,10r)-2,4-bis(acetyloxy)-3-isopropyl-6,10-dimethyl-11-oxabicyclo[8.1.0]undec-6-en-5-yl (2e)-2-methylbut-2-enoate

C24H36O7 (436.2460906)


   

(1r,2s,5s,6r,10r,11s,12r,15r,19s)-11-ethoxy-6-(furan-3-yl)-1,5,10,15-tetramethyl-13-oxapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹⁵,¹⁹]nonadeca-8,16-dien-18-one

(1r,2s,5s,6r,10r,11s,12r,15r,19s)-11-ethoxy-6-(furan-3-yl)-1,5,10,15-tetramethyl-13-oxapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹⁵,¹⁹]nonadeca-8,16-dien-18-one

C28H36O4 (436.2613456)


   

(2r,3r,4s,5r)-3,5-dihydroxy-2-[(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy]oxan-4-yl 2-methylbut-2-enoate

(2r,3r,4s,5r)-3,5-dihydroxy-2-[(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy]oxan-4-yl 2-methylbut-2-enoate

C25H40O6 (436.28247400000004)


   

(6bs,7s,8as,11r,12ar,12bs,14as)-3,7-dihydroxy-4,6b,8a,11,12b,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-dione

(6bs,7s,8as,11r,12ar,12bs,14as)-3,7-dihydroxy-4,6b,8a,11,12b,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-dione

C28H36O4 (436.2613456)


   

ethyl 3,5-dihydroxy-7-{2-methyl-8-[(2-methylbutanoyl)oxy]-1,2,6,7,8,8a-hexahydronaphthalen-1-yl}heptanoate

ethyl 3,5-dihydroxy-7-{2-methyl-8-[(2-methylbutanoyl)oxy]-1,2,6,7,8,8a-hexahydronaphthalen-1-yl}heptanoate

C25H40O6 (436.28247400000004)


   

1-[(1r,2r,4ar,8ar)-1-[(4s)-4,5-dihydroxy-3-methylidenepentyl]-1,4a,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-2-yl]methyl 4-methyl butanedioate

1-[(1r,2r,4ar,8ar)-1-[(4s)-4,5-dihydroxy-3-methylidenepentyl]-1,4a,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-2-yl]methyl 4-methyl butanedioate

C25H40O6 (436.28247400000004)


   

5-[4-hydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-6-[(3-methylbutanoyl)oxy]-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-2-enoic acid

5-[4-hydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-6-[(3-methylbutanoyl)oxy]-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-2-enoic acid

C25H40O6 (436.28247400000004)


   

(8ar,9s,10r,11s,12as,12bs,14as)-3,9,10-trihydroxy-4,7,8a,11,12b,14a-hexamethyl-8,9,10,11,12,12a,13,14-octahydropicen-2-one

(8ar,9s,10r,11s,12as,12bs,14as)-3,9,10-trihydroxy-4,7,8a,11,12b,14a-hexamethyl-8,9,10,11,12,12a,13,14-octahydropicen-2-one

C28H36O4 (436.2613456)


   

methyl (3r)-5-[(1r,2s,3r,4r,4ar,8ar)-3,4-bis(acetyloxy)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]-3-methylpentanoate

methyl (3r)-5-[(1r,2s,3r,4r,4ar,8ar)-3,4-bis(acetyloxy)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]-3-methylpentanoate

C25H40O6 (436.28247400000004)


   

(1s,2r,3r,4s,6s,9s,10s,11s,13s,15r)-6-(acetyloxy)-2,11,15-trihydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-3-yl acetate

(1s,2r,3r,4s,6s,9s,10s,11s,13s,15r)-6-(acetyloxy)-2,11,15-trihydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-3-yl acetate

C24H36O7 (436.2460906)


   

9,10,15,18-tetrahydroxy-12,12-dimethyl-6-methylidene-16-(2-methylpropoxy)-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-7-one

9,10,15,18-tetrahydroxy-12,12-dimethyl-6-methylidene-16-(2-methylpropoxy)-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-7-one

C24H36O7 (436.2460906)